Stock listing

DNA Stock Price, News, Filings & Events — Ginkgo Bioworks Holdings, Inc.

Selected listing: DNA · BIVA · MXN · MX

This page tracks Ginkgo Bioworks Holdings, Inc.'s DNA:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DNA:BIVA. DNA:BIVA is the stock-level entry point for investors researching Ginkgo Bioworks Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ginkgo Bioworks Holdings, Inc. is a public company traded under the ticker DNA in the American market. The company has a market capitalization of approximately $480.79 million. Ginkgo Bioworks specializes in using biotechnology to design custom microbes for various applications across different industries.

DNA:BIVAMXNMXUpdated August 21, 2026
Ginkgo Bioworks Holdings, Inc. logo
Ticker
DNA:BIVA
Asset type
Stock
Market cap
$498.3M
Sector
Health Services
Industry
Medical/Nursing Services
Exchange
BIVA
Currency
MXN

Ginkgo Bioworks Holdings, Inc. DNA:BIVA stock context

This page tracks Ginkgo Bioworks Holdings, Inc.'s DNA:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DNA:BIVA. DNA:BIVA is the stock-level entry point for investors researching Ginkgo Bioworks Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ginkgo Bioworks Holdings, Inc. is a public company traded under the ticker DNA in the American market. The company has a market capitalization of approximately $480.79 million. Ginkgo Bioworks specializes in using biotechnology to design custom microbes for various applications across different industries.

Latest news from Ginkgo Bioworks Holdings, Inc.

All Ginkgo Bioworks Holdings, Inc. news →

Research Ginkgo Bioworks Holdings, Inc.

Alternate listings